{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T00:57:27Z","timestamp":1791593847984,"version":"4.3.4"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","license":[{"start":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T00:00:00Z","timestamp":1738281600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,1,31]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Pregnancy-associated atypical hemolytic uremic syndrome (p-aHUS) is a rare, life-threatening condition characterized by microangiopathic hemolytic anemia, thrombocytopenia, elevated liver enzymes, and acute kidney injury. Prompt diagnosis and therapy are crucial due to the high risk of progression to chronic kidney disease (CKD), end-stage kidney disease (ESKD), and dialysis dependency, as well as significant maternal and fetal morbidity and mortality.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>A comprehensive literature search was conducted across EMBASE, MEDLINE, and the Cochrane CENTRAL from January 2000 to March 2024. Studies reporting on pregnancy and kidney outcomes in women diagnosed with p-aHUS were included.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Ten studies involving 386 pregnancies in 380 patients met the inclusion criteria for the final analysis. Renal outcomes varied, with mean creatinine levels ranging from 0.72 to 8.734\u2005mg\/dL. Dialysis was required in 66.6% of patients, and 25% developed ESKD. Maternal complications included preeclampsia (36.4%) and hemolysis, elevated liver enzymes, and low platelets syndrome (29.7%), with a 5% maternal mortality rate. Fetal complications included intrauterine fetal demise (n\u2005=\u200525), intrauterine growth restriction, low birth weight, and prematurity. Treatment with eculizumab significantly reduced the risk of CKD and ESKD, with a pooled risk ratio of 0.20 (95% confidence interval: 0.09\u20130.44) and low heterogeneity (<jats:italic toggle=\"yes\">I<\/jats:italic>\u00b2\u2005=\u20050%, <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u2005.43).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>This analysis highlights the severe kidney and pregnancy outcomes associated with p-aHUS. Eculizumab treatment is significantly beneficial in reducing the risk of CKD and ESKD.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000041403","type":"journal-article","created":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T20:00:08Z","timestamp":1738353608000},"page":"e41403","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":11,"title":["Kidney and pregnancy outcomes in pregnancy-associated atypical hemolytic uremic syndrome: A systematic review and meta-analysis"],"prefix":"10.1097","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6073-8101","authenticated-orcid":false,"given":"Priti","family":"Meena","sequence":"first","affiliation":[{"name":"Department of Nephrology, All India Institute of Medical Sciences, Bhubaneswar, Odisha, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-2584-9668","authenticated-orcid":false,"given":"Ruju","family":"Gala","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Zynova Shalby Hospital, Mumbai, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rashmi Ranjan","family":"Das","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, All India Institute of Medical Sciences, Bhubaneswar, Odisha, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3360-4666","authenticated-orcid":false,"given":"Vinant","family":"Bhargava","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Sir Ganga Ram Hospital, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yellampalli","family":"Saivani","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Santhiram Medical College, Nadyal, Andhra Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4487-8600","authenticated-orcid":false,"given":"Sandip","family":"Panda","sequence":"additional","affiliation":[{"name":"Department of Nephrology, All India Institute of Medical Sciences, Bhubaneswar, Odisha, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7163-8800","authenticated-orcid":false,"given":"Alok","family":"Mantri","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Kalinga Hospital, Bhubaneswar, Odisha, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4148-6903","authenticated-orcid":false,"given":"Krishna Kumar","family":"Agrawaal","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Universal College of Medical Sciences, Bhairahawa, Siddhartha Nagar, Nepal."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250131","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.kint.2016.10.005","article-title":"Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a \u201cKidney Disease: Improving Global Outcomes\u201d (KDIGO) Controversies Conference.","volume":"91","author":"Goodship","year":"2017","journal-title":"Kidney Int"},{"key":"R2-20250131","doi-asserted-by":"crossref","first-page":"554","DOI":"10.2215\/CJN.04760512","article-title":"Genetics and outcome of atypical hemolytic uremic syndrome: a nationwide French series comparing children and adults.","volume":"8","author":"Fremeaux-Bacchi","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"key":"R3-20250131","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s00431-009-1079-9","article-title":"Hemolytic-uremic syndrome in Switzerland: a nationwide surveillance 1997\u20132003.","volume":"169","author":"Schifferli","year":"2010","journal-title":"Eur J Pediatr"},{"key":"R4-20250131","doi-asserted-by":"crossref","first-page":"557","DOI":"10.2215\/CJN.11470918","article-title":"Etiology and outcomes of thrombotic microangiopathies.","volume":"14","author":"Bayer","year":"2019","journal-title":"Clin J Am Soc Nephrol"},{"key":"R5-20250131","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1097\/AOG.0000000000003554","article-title":"Pregnancy-associated atypical hemolytic uremic syndrome: a systematic review.","volume":"135","author":"Gupta","year":"2020","journal-title":"Obstet Gynecol"},{"key":"R6-20250131","first-page":"662","article-title":"The long-term consequences of thrombotic microangiopathy (thrombotic thrombocytopenic purpura and hemolytic uremic syndrome) in pregnancy.","volume":"91","author":"Dashe","year":"1998","journal-title":"Obstet Gynecol"},{"key":"R7-20250131","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1016\/j.ekir.2019.07.016","article-title":"Eculizumab safety: five-year experience from the global atypical hemolytic uremic syndrome registry.","volume":"4","author":"Rondeau","year":"2019","journal-title":"Kidney Int Rep"},{"key":"R8-20250131","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1093\/ndt\/gfw314","article-title":"Atypical haemolytic uraemic syndrome and pregnancy: outcome with ongoing eculizumab.","volume":"31","author":"Servais","year":"2016","journal-title":"Nephrol Dial Transplant"},{"key":"R9-20250131","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1681\/ASN.2016090995","article-title":"Maternal and fetal outcomes of pregnancies in women with atypical hemolytic uremic syndrome.","volume":"29","author":"Gaggl","year":"2018","journal-title":"J Am Soc Nephrol"},{"key":"R10-20250131","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.2215\/CJN.00280117","article-title":"Hemolytic uremic syndrome in pregnancy and postpartum.","volume":"12","author":"Bruel","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"key":"R11-20250131","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.kint.2017.06.022","article-title":"A retrospective study of pregnancy-associated atypical hemolytic uremic syndrome.","volume":"93","author":"Huerta","year":"2018","journal-title":"Kidney Int"},{"key":"R12-20250131","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.ekir.2018.11.012","article-title":"Postpartum renal cortical necrosis is associated with atypical hemolytic uremic syndrome in developing countries.","volume":"4","author":"Ramachandran","year":"2019","journal-title":"Kidney Int Rep"},{"key":"R13-20250131","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.12669\/pjms.36.6.2931","article-title":"Hemolytic uremic syndrome associated with pregnancy: outcome from acute kidney injury.","volume":"36","author":"Naqvi","year":"2020","journal-title":"Pak J Med Sci"},{"key":"R14-20250131","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1111\/bjh.16626","article-title":"The natural course of pregnancies in women with primary atypical haemolytic uraemic syndrome and asymptomatic relatives.","volume":"190","author":"Timmermans","year":"2020","journal-title":"Br J Haematol"},{"key":"R15-20250131","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1007\/s40620-021-01025-x","article-title":"Pregnancy-triggered atypical hemolytic uremic syndrome (aHUS): a Global aHUS Registry analysis.","volume":"34","author":"Fakhouri","year":"2021","journal-title":"J Nephrol"},{"key":"R16-20250131","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000518171","article-title":"Pregnancy in women with atypical hemolytic uremic syndrome.","volume":"146","author":"Rondeau","year":"2022","journal-title":"Nephron"},{"key":"R17-20250131","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1093\/ndt\/gfae068","article-title":"Eculizumab for pregnancy-related atypical hemolytic uremic syndrome.","volume":"39","author":"Korotchaeva","year":"2024","journal-title":"Nephrol Dial Transplant"},{"key":"R18-20250131","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1053\/j.ajkd.2015.12.034","article-title":"Terminal complement inhibitor eculizumab in adult patients with atypical hemolytic uremic syndrome: a single-arm, open-label trial.","volume":"68","author":"Fakhouri","year":"2016","journal-title":"Am J Kidney Dis"},{"key":"R19-20250131","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1056\/NEJMoa1208981","article-title":"Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome.","volume":"368","author":"Legendre","year":"2013","journal-title":"N Engl J Med"},{"key":"R20-20250131","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/ejh.14026","article-title":"Molecular pharmacology in complement-mediated hemolytic disorders.","volume":"111","author":"Bortolotti","year":"2023","journal-title":"Eur J Haematol"},{"key":"R21-20250131","article-title":"US Food and Drug Administration Soliris (eculizumab)."}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000041403","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T20:00:14Z","timestamp":1738353614000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000041403"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,31]]},"references-count":21,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000041403","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,31]]}}}